Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News Can High Tide’s Remexian acquisition turn it into a global cannabis leader? €26.4m deal explained High Tide acquires 51% of Germany's Remexian Pharma for €26.4M with a 5-year full buyout option. Find out how this move expands its global cannabis reach. byPallavi MadhirajuSeptember 2, 2025